Corbus Pharma (CRBP) Misses Q3 EPS by 190c
Tweet
Share
E-mailCorbus Pharma (NASDAQ: CRBP) reported Q3 EPS of ($1.90).
For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform
- HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
